# Effects of Psyllium on Niacin Tolerability

> **NCT03370848** · PHASE4 · COMPLETED · sponsor: **VA Greater Los Angeles Healthcare System** · enrollment: 26 (actual)

## Conditions studied

- Flushing
- Hyperlipidemias
- Dyslipidemias

## Interventions

- **DIETARY_SUPPLEMENT:** Psyllium
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT03370848
- **Lead sponsor:** VA Greater Los Angeles Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2017-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03370848

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03370848, "Effects of Psyllium on Niacin Tolerability". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03370848. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*